Frezzotti Paolo

Michelessi Manuele, Quaranta Luciano, Riva Ivano, Martini Enrico, Figus Michele, Frezzotti Paolo et al.

This study found OCT's clinical reference database for minimum rim width (MRW) is less sensitive for glaucoma diagnosis than continuous parameters, highlighting a gap between research and clinical utility.

Michelessi Manuele, Riva Ivano, Martini Enrico, Figus Michele, Frezzotti Paolo, Agnifili Luca et al.

This study found that optic nerve head (MRW) and nerve fiber layer (pRNFL) imaging are superior to macular OCT for diagnosing early glaucoma, offering better diagnostic accuracy.

Fea Antonio M, Ahmed Iqbal Ike K, Lavia Carlo, Mittica Pietro, Consolandi Giulia, Motolese Ilaria et al.

This study compared Hydrus microstent to SLT for glaucoma. Hydrus significantly reduced medication dependence more than SLT at one year, offering a valuable option for patients seeking fewer eye drops.

Agnifili Luca, Fasanella Vincenzo, Mastropasqua Rodolfo, Frezzotti Paolo, Curcio Claudia, Brescia Lorenza et al.

Preoperative conjunctival goblet cell density predicts trabeculectomy success, suggesting it could be a biomarker for surgical outcome.

Agnifili Luca, Mastropasqua Rodolfo, Frezzotti Paolo, Fasanella Vincenzo, Motolese Ilaria, Pedrotti Emilio et al.

This study found glaucoma patients, especially POAG, have higher nocturnal IOP peaks than healthy subjects. Continuous 24-hour monitoring is crucial for comprehensive glaucoma management, as diurnal IOP doesn't predict nocturnal patterns.

Frezzotti Paolo, Fogagnolo Paolo, Haka Gentiana, Motolese Ilaria, Iester Michele, Bagaglia Simone A et al.

This study found preservative-free timolol gel causes fewer conjunctival goblet cell changes and less dry eye than preserved timolol, highlighting its benefit for long-term glaucoma treatment adherence.

Agnifili Luca, Fasanella Vincenzo, Costagliola Ciro, Ciabattoni Cristina, Mastropasqua Rodolfo, Frezzotti Paolo et al.

Confocal microscopy revealed anti-glaucoma medications, especially preserved PGAs, cause meibomian gland damage. This impacts ocular surface health, highlighting the need for MG evaluation in glaucoma patients.

Frezzotti Paolo, Pescucci Chiara, Papa Filomena Tiziana, Iester Michele, Mittica Vincenzo, Motolese Ilaria et al.

WDR36 gene variants were studied in Italian POAG families. Findings suggest WDR36 is a rare cause of glaucoma in this population, implying limited clinical relevance for routine genetic screening.

Fogagnolo Paolo, Sangermani Chiara, Oddone Francesco, Frezzotti Paolo, Iester Michele, Figus Michele et al.

This study found visual field fluctuation peaks in moderate-severe glaucoma (GSS2 stage 4), decreasing in early/late stages. Clinically, understanding this variability helps differentiate true progression from normal test-retest changes.

Frezzotti Paolo, Mittica Vincenzo, Martone Gianluca, Motolese Ilaria, Lomurno Luca, Peruzzi Sabrina et al.

TDLCP effectively lowers IOP in advanced refractory glaucoma, but often requires retreatment, demonstrating its safety and efficacy for these challenging cases.

Iester Michele, Mete Maurizio, Figus Michele, Frezzotti Paolo

Central corneal thickness (CCT) significantly impacts glaucoma risk and progression, particularly in ocular hypertension or higher IOP. Therefore, CCT measurement is crucial for accurate IOP interpretation and glaucoma management.

Martone Gianluca, Frezzotti Paolo, Tosi Gian Marco, Traversi Claudio, Mittica Vincenzo, Malandrini Alex et al.

Preservative-containing glaucoma drops significantly damage the corneal surface and nerves compared to preservative-free drops. This highlights the need for less toxic treatments to improve patient comfort and adherence.

Ariani Francesca, Longo Ilaria, Frezzotti Paolo, Pescucci Chiara, Mari Francesca, Caporossi Aldo et al.

This study found optineurin gene mutations are not associated with common high-tension primary open-angle glaucoma. This suggests optineurin's role is limited in this prevalent glaucoma form.